Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.
Matsushima
M
M
First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Miki
K
K
Ichinose
M
M
Kakei
N
N
Yahagi
N
N
Kido
M
M
Shimizu
Y
Y
Ishihama
S
S
Tsukada
S
S
Kurokawa
K
K
D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000201:enzymology; D005500:Follow-Up Studies; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010435:Pepsinogens / Q000097:blood*; D010437:Peptic Ulcer / Q000175:diagnosis* / Q000188:drug therapy* / Q000201:enzymology; D012008:Recurrence; D013276:Stomach Ulcer / Q000175:diagnosis / Q000201:enzymology; D013997:Time Factors
D000897:Anti-Ulcer Agents; D015415:Biomarkers; D006635:Histamine H2 Antagonists; D010435:Pepsinogens